US Stock MarketDetailed Quotes
ABT Abbott Laboratories
- 107.530
- +0.670+0.63%
Close Apr 26 16:00 ET
- 107.440
- -0.090-0.08%
Post 19:12 ET
186.58BMarket Cap33.50P/E (TTM)
107.856High106.390Low3.58MVolume106.510Open106.860Pre Close384.26MTurnover0.21%Turnover Ratio32.98P/E (Static)1.74BShares121.03952wk High4.83P/B185.37BFloat Cap88.80152wk Low2.08Dividend TTM1.72BShs Float136.153Historical High1.93%Div YieldTTM1.37%Amplitude6.525Historical Low107.467Avg Price1Lot Size
Abbott Laboratories Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -24.21%7.26B | 30.61%3.04B | -32.48%1.88B | -50.08%1.2B | -44.65%1.14B | -9.04%9.58B | -24.16%2.33B | 2.92%2.78B | 13.25%2.41B | -21.69%2.07B |
| Net income from continuing operations | -17.45%5.72B | 54.31%1.59B | 0.07%1.44B | -31.86%1.38B | -46.14%1.32B | -1.95%6.93B | -48.06%1.03B | -31.67%1.44B | 69.72%2.02B | 36.48%2.45B |
| Operating gains losses | -41.40%126M | ---- | ---- | ---- | ---- | 290.91%215M | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -0.73%3.24B | 0.74%813M | 1.10%824M | -2.68%800M | -2.07%806M | -7.66%3.27B | -8.61%807M | -3.78%815M | -5.95%822M | -11.88%823M |
| Other non cash items | ---- | ---- | -352.11%-179M | -817.39%-660M | -424.88%-1.08B | ---- | ---- | 291.89%71M | 194.85%92M | -3,316.67%-205M |
| Change In working capital | -62.94%-2.48B | -1,436.84%-1.52B | -195.54%-321M | 33.13%-444M | 85.75%-186M | -97.02%-1.52B | 207.55%114M | 204.02%336M | -2,313.33%-664M | -250.81%-1.31B |
| -Change in receivables | -423.53%-356M | -80.06%68M | -186.98%-461M | -4.26%-196M | 131.03%233M | 82.25%-68M | 280.42%341M | 234.52%530M | -637.14%-188M | -555.15%-751M |
| -Change in inventory | 83.58%-232M | 256.08%295M | 172.16%140M | 47.90%-248M | 24.37%-419M | -209.87%-1.41B | -1,360.00%-189M | -373.24%-194M | -9,420.00%-476M | -3.17%-554M |
| -Change in prepaid assets | -622.67%-542M | ---- | ---- | ---- | ---- | 75.96%-75M | ---- | ---- | ---- | ---- |
| -Change in payables and accrued expense | -280.95%-760M | ---- | ---- | ---- | ---- | -67.39%420M | ---- | ---- | ---- | ---- |
| -Change in other working capital | -52.74%-585M | ---- | ---- | ---- | ---- | 57.82%-383M | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -24.21%7.26B | 30.61%3.04B | -32.48%1.88B | -50.08%1.2B | -44.65%1.14B | -9.04%9.58B | -24.16%2.33B | 2.92%2.78B | 13.25%2.41B | -21.69%2.07B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -80.06%-3.13B | -30.38%-824M | -30.99%-634M | -359.47%-1.21B | -28.33%-462M | 13.35%-1.74B | 5.81%-632M | 25.65%-484M | 0.00%-264M | 14.69%-360M |
| Net PPE purchase and sale | -23.92%-2.2B | -23.77%-755M | -19.91%-560M | -33.77%-507M | -18.38%-380M | 5.73%-1.78B | 0.65%-610M | -1.30%-467M | 8.23%-379M | 19.14%-321M |
| Net business purchase and sale | -1,843.75%-837M | --0 | ---51M | ---- | ---- | 190.57%48M | --0 | --0 | ---- | ---- |
| Net investment purchase and sale | -251.52%-116M | -136.67%-71M | -80.95%-38M | 33.90%79M | -109.76%-86M | 65.63%-33M | 56.52%-30M | 80.56%-21M | -37.89%59M | -192.86%-41M |
| Net other investing changes | 0.00%22M | -75.00%2M | 275.00%15M | -87.50%1M | 100.00%4M | -15.38%22M | -33.33%8M | 0.00%4M | 33.33%8M | -50.00%2M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -80.06%-3.13B | -30.38%-824M | -30.99%-634M | -359.47%-1.21B | -28.33%-462M | 13.35%-1.74B | 5.81%-632M | 25.65%-484M | 0.00%-264M | 14.69%-360M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 7.14%-7.09B | -40.84%-2.05B | -51.65%-2.34B | -58.55%-1.29B | 63.12%-1.41B | -38.99%-7.64B | 22.75%-1.46B | -12.06%-1.54B | 35.68%-813M | -295.35%-3.82B |
| Net issuance payments of debt | -254.08%-2.48B | -9,490.00%-939M | -6,375.00%-1.51B | 20.00%12M | 94.35%-42M | -181.85%-699M | 105.10%10M | 135.82%24M | 242.86%10M | -3,477.27%-743M |
| Net common stock issuance | 67.67%-1.23B | 62.19%-259M | 99.75%-2M | -8,420.00%-426M | 76.59%-540M | -65.07%-3.8B | 29.67%-685M | -37.82%-798M | 98.94%-5M | -738.91%-2.31B |
| Cash dividends paid | -7.46%-3.56B | -7.90%-888M | -7.51%-888M | -7.49%-890M | -6.97%-890M | -3.34%-3.31B | -3.13%-823M | -3.12%-826M | -3.11%-828M | -4.00%-832M |
| Proceeds from stock option exercised by employees | 0.00%167M | -17.07%34M | -1.75%56M | 50.00%15M | 5.08%62M | -34.51%167M | -50.00%41M | -18.57%57M | -41.18%10M | -31.40%59M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 7.14%-7.09B | -40.84%-2.05B | -51.65%-2.34B | -58.55%-1.29B | 63.12%-1.41B | -38.99%-7.64B | 22.75%-1.46B | -12.06%-1.54B | 35.68%-813M | -295.35%-3.82B |
| Net cash flow | ||||||||||
| Beginning cash position | 0.85%9.88B | -30.07%6.71B | -12.33%7.84B | 19.36%9.16B | 0.85%9.88B | 43.30%9.8B | 3.14%9.59B | 3.22%8.94B | -4.71%7.68B | 43.30%9.8B |
| Current changes in cash | -1,545.37%-2.96B | -31.65%162M | -245.68%-1.1B | -197.45%-1.3B | 65.58%-729M | -93.24%205M | -53.53%237M | 11.89%753M | 122.17%1.33B | -269.71%-2.12B |
| Effect of exchange rate changes | 81.15%-23M | -50.98%25M | 69.79%-29M | 61.97%-27M | 233.33%8M | -74.29%-122M | 492.31%51M | -231.03%-96M | -1,875.00%-71M | 81.25%-6M |
| End cash Position | -30.22%6.9B | -30.22%6.9B | -30.07%6.71B | -12.33%7.84B | 19.36%9.16B | 0.85%9.88B | 0.85%9.88B | 3.14%9.59B | 3.22%8.94B | -4.71%7.68B |
| Free cash flow | -35.17%5.06B | 33.04%2.28B | -43.06%1.32B | -65.73%696M | -56.25%763M | -9.76%7.8B | -30.04%1.72B | 3.26%2.31B | 18.43%2.03B | -22.14%1.74B |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg